Stock News & Analysis

The medical technology company reported a notable insider sale as shares returned 35% over the past year.

Coty will try to turn around its beauty business in fiscal 2027.

Buffett is widely considered the best investor of all time.

ScanSource's fiscal Q4 report arrived with plenty for shareholders to be happy about.

After sixty years of avoiding department stores, Berkshire is dipping a toe back in.

The hedge fund legend has bet much of the family office on this one diagnostics company.

Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.

David Tepper added shares of Amazon, Meta, Alphabet, and Nvidia to his portfolio in Q2.

Barrick saw attributable adjusted EBITDA and earnings rise in the second quarter.

The First Commonwealth Financial stock price has performed well thus far in 2026, and while Grebenc sold some of her direct holdings, she still maintains a large stake in the company.

While initial estimates are calling for a larger boost next year, the number could still shift.

Costco just gave shareholders a 13% dividend raise, but don't expect to retire on the income alone.

SpaceX has a lot of work to do just to justify its current valuation.

It's not free, but it could make a big difference to your future tax bills.

Insider disposed of 17% of direct holdings at $53 per share, reducing equity interest while stock trades near transaction price.

Joby maintains a strong cash position despite heavy spending.

XBI is up nearly 80% over the past year, but has experienced a much larger maximum drawdown over the past five years. IHE has delivered steadier returns and offers a higher dividend yield.

Beverly O. Elving exercised options at $19.72 per share and immediately liquidated the position, retaining 12,786 shares worth $522,691.

This ETF blows away the Vanguard S&P 500 ETF.

The stock price has surged over the last 12 months after underperforming for the last five years, offering a chance to lock in some profits.